SEARCH

SEARCH BY CITATION

References

  • BEHL, C., WIDMANN, M., TRAPP, T. & HOLSBOER, F. (1995). 17-βEstradiol protect neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun., 216, 473482.
  • BRENNER, D.E., KUKULL, W.A., STERGACHIS, A., VAN BELLE, G., BOWEN, J.D., MCCORMICK, W.C., TERI, L. & LARSON, E.B. (1994). Postmenopausal estrogen replacement therapy and risk of Alzheimer's disease: a population-based case-control study. Am. J. Epidemiol., 140, 262267.
  • DANIEL, J.M., FADER, A.J., SPENCER, A.L. & DOHANICH, G.P. (1997). Estrogen enhances performance of female rats during acquisition of a radial arm maze. Horm. Behav., 32, 217225.
  • DIAMOND, D.M, FLESHNER, M., INGERSOLL, N. & ROSE, G.M. (1996). Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function. Behav. Neurosci., 110, 661672.
  • DOHANICH, G.P., WITCHER, J.A., WEAVER, D.R. & CLEMENS, L.G. (1982). Alteration of muscarinic binding in specific brain areas following estrogen treatment. Brain Res., 241, 347350.
  • FILLIT, H., WEINREB, H., CHOLST, I., LUINE, V., MCEWEN, B., AMADOR, B. & ZABRISKIE, J. (1986). Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology, 11, 337345.
  • FUJI, K., HIRAMATSU, M., KAMEYAMA, T. & NABESHIMA, T. (1993). Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. Eur. J. Pharmacol., 236, 411417.
  • GAMES, D., ADAMS, D., ALESSANDRINI, R., BARBOUR, R., BERTHELETTE, P., BLACKWELL, C., CARR, T., CLEMENS, J., DONALDSON, T., GILLESPIE, F., GUIDO, T., HAGOPIAN, S., JOHNSON-WOOD, K., KHAN, K., LEE, M., LEIBOWITZ, P., LIEBERBURG, I., LITTLE, S., MASLIAH, E., MCCONLOGUE, L., MONTOYA-ZAVALA, M., MUCKE, L., PAGANINI, L., PENNIMAN, E., ROWER, M., SCHENK, D., SEUBERT, D., SNYDER, B., SORIANO, F., TAN, H., VITALE, J., WADSWORTH, S., WOLOZIN, B. & ZHAO, J. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717Fβ-amyloid precursor protein. Nature, 373, 523527.
  • GIBBS, R.B. (1998). Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol., 151, 289302.
  • GOODMAN, Y., BRUCE, A.J., CHENG, B. & MATTSON, M.P. (1996). Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem., 66, 18361844.
  • HENDERSON, V.W. (1997). The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology, 48, (Suppl.7): S27S35.
  • HENDERSON, V.W., PAGANINI-HILL, A., EMANUEL, C.K., DUNN, M.E. & BUCKWALTER, J.G. (1994). Estrogen replacement therapy in older women: comparisons between Alzheimer's disease case and nondemented control subjects. Arch Neurol., 51, 896900.
  • ITOH, A., NITTA, A., NADAI, M., NISHIMURA, M., HIROSE, M., HASEGAWA, T. & NABESHIMA, T. (1996). Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem., 66, 11131117.
  • IWATSUBO, T., ODAKA, A., SUZUKI, N., MIZUSAWA, H., NUKINA, N. & IHARA, Y. (1994). Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron, 13, 4553.
  • JAFFE, A.B., TORAN-ALLERAND, C.D., GREENGARD, P. & GANDY, S.E. (1994). Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J. Biol. Chem., 269, 1306513068.
  • JARRETT, J.T. & LANSBURY, JR, P.T. (1993). Seeding ‘one-dimensional crystallization’ of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie Cell, 73, 10551058.
  • JOHNSON-WOOD, K., LEE, M., MOTTER, R., HU, K., GORDON, G., BARBOUR, R., KHAN, K., GORDON, M., TAN, H., GAMES, D., LIEBERBURG, I., SCHENK, D., SEUBERT, P. & MCCONLOGUE, L. (1997). Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A., 94, 15501555.
  • JORM, A.F., KORTEN, A.E. & HENDERSONM, A.S. (1987). The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand., 76, 465479.
  • KAR, S., ISSA, A.M., SETO, D., AULD, D.S., COLLIER, B. & QUIRION, R. (1998). Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J. Neurochem., 70, 21792187.
  • KOH, J.-Y., YANG, L.L. & COTMAN, C.W. (1990). β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res., 533, 315320.
  • MATTSON, M.P., CHENG, B., DAVIS, D., BRYANT, K., LIEBERBURG, I. & RYDEL, R.E. (1992). β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci., 12, 376389.
  • MAURICE, T., HIRAMATSU, M., ITOH, J., KAMEYAMA, T. & NABESHIMA, T. (1994). Behavioural evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res., 647, 4456.
  • MORRIS, R.G.M. (1984). Developments of water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods, 11, 4760.
  • MORRIS, R.G.M., SCHENK, F., TWEEDIE, F. & JARRARD, L.E. (1990). Ibotenate lesions of hippocampus and/or subiculum: dissociating components of allocentric spatial learning. Eur. J. Neurosci., 2, 10161028.
  • NABESHIMA, T. & ITOH, A. (1997). Toxicity of β-amyloid protein: neurochemical histological and behavioral changes. In Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. & Wisniewski, H.M. (eds) Alzheimer's Disease: Biology, Diagnosis and Therapeutics. John Wiley & Sons Ltd., England, pp 623630.
  • NITTA, A., FUKUTA, T., HASEGAWA, T. & NABESHIMA, T. (1997). Continuous infusion of β-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn. J. Pharmacol., 73, 5157.
  • NITTA, A., ITOH, A., HASEGAWA, T. & NABESHIMA, T. (1994). β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci. Lett., 170, 6366.
  • OHKURA, T., ISSE, K., AKAZAWA, K., HAMAMOTO, M., YAOI, Y. & HAGINO, N. (1994). Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocri. J., 41, 361371.
  • PAXINOS, G. & WATSON, C. (1986). The Rat Brain in the Stereotaxic Coordinates. Academic Press, New York.
  • SELDEN, N.R.W., COLE, B.J., EVERITT, B.J. & ROBBINS, T.W. (1990). Damage to ceruleo-cortical noradrenergic projections impairs locally cued but enhances spatially cued water maze acquisition. Behav. Brain Res., 39, 2951.
  • SELKOE, D.J. (1996). Amyloid b-protein and the genetics of Alzheimer's disease. J. Biol. Chem., 271, 1829518298.
  • SHIMIZU, H. & BRAY, G.A. (1993). Effects of castration, estrogen replacement and estrus cycle on monoamine metabolism in the nucleus accumbens, measured by microdialysis. Brain Res., 621, 200206.
  • SINGH, M., MEYER, E.M., MILLARD, W.J. & SIMPKINS, J.W. (1994). Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res., 644, 305312.
  • SINGH, M., MEYER, E.M. & SIMPKINS, J.W. (1995). The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology, 136, 23202324.
  • STURCHLER-PIERRAT, C., ABRAMOWSKI, D., DUKE, M., WIEDERHOLD, K.-H., MISTL, C., ROTHACHER, S., LEDERMANN, B., BURKI, K., FREY, P., PAGANETTI, P.A., WARIDEL, C., CALHOUN, M., JUCKER, M., PROBST, A., STAUFENBIEL, M. & SOMMER, B. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A., 94, 1328713292.
  • TANAKA, T., YAMADA, K., SENZAKI, K., NARIMATSU, H., NISHIMURA, K., KAMEYAMA, T. & NABESHIMA, T. (1998). NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by β-amyloid protein in rats. Eur. J. Pharmacol., 349, 1522.
  • TANG, M.-X., JACOBS, D., STERN, Y., MARDER, K., SCHOFIELD, P., GURLAND, B., ANDREWS, H. & MAYEUX, R. (1996). Effects of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429432.
  • XU, H., GOURAS, G.K., GREENFIELD, J.P., VINCENT, B., NASLUND, J., MAZZARELLI, L., FRIED, G., JOVANOVIC, J.N., SEEGER, M., RELKIN, N.R., LIAO, F., CHECLER, F., BUXBAUM, J.D., CHAIT, B.T., THINAKARAN, G., SISODIA, S., WANG, R., GREENGARD, P. & GANDY, S. (1998). Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nature Med., 4, 447451.
  • YAMADA, K., NITTA, A., SAITO, T., HU, J. & NABESHIMA, T. (1995). Changes in ciliary neurotrophic factor content in the rat brain after continuous intracerebroventricular infusion of β-amyloid (1-40) protein. Neurosci. Lett., 201, 155158.
  • YAMADA, K., NODA, Y., HASEGAWA, T., KOMORI, T., NIKAI, T., SUGIHARA, H. & NABESHIMA, T. (1996). The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behaviour in mice. J. Pharmacol. Exp. Ther., 276, 460466.
  • YAMADA, K., TANAKA, T., HAN, D., SENZAKI, K., KAMEYAMA, T. & NABESHIMA, T. (1999b). Protective effects of idebenone and α-tocopherol on β-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in β-amyloid-induced neurotoxicity in vivo. Eur. J. Neurosci., 11, 8390.
  • YAMADA, K., TANAKA, T., MAMIYA, T., SHIOTANI, T., KAMEYAMA, T. & NABESHIMA, T. (1999a). Improvement of nefiracetam of β-amyloid-(1-42)-induced learning and memory impairments in rats. Br. J. Pharmacol., 126, 235244.
  • YAMADA, K., TANAKA, T., SENZAKI, K., KAMEYAMA, T. & NABESHIMA, T. (1998). Propentofylline improves learning and memory deficits in rats induced by β-amyloid protein-(1-40). Eur. J. Pharmacol., 349, 1522.
  • YAMADA, K., TANG, Y.-P., KANO, Y., MIYAZAKI, T., MURATA, Y., SEO, H. & NABESHIMA, T. (1997). Continuous infusion of β-amyloid into the cerebral ventricle of rats promotes expression of BDNF messenger RNA in the hippocampus. Neurosci. Res., 22 (Suppl.): S36.
  • YAMAMURA, K., IWATA, H., OSADA, T., YANO, K., YOTSUYANAGI, T. & NABESHIMA, T. (1995). Prevention of bone loss by percutaneous estradiol implants in ovariectomized rats. J. Biomed. Mater. Res., 29, 12491253.
  • YANKNER, B.A. (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron, 16, 921932.
  • YANKNER, B.A., DUFFY, L.K. & KIRSCHNER, D.A. (1990). Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science, 250, 279282.